Unique ID issued by UMIN | UMIN000023007 |
---|---|
Receipt number | R000026521 |
Scientific Title | Longitudinal study for Cognitive function and Brain structural changes associated with Ablation-therapy for Atrial fibrillation |
Date of disclosure of the study information | 2016/07/10 |
Last modified on | 2023/07/10 10:17:46 |
Longitudinal study for Cognitive function and Brain structural changes associated with Ablation-therapy for Atrial fibrillation
Longitudinal study for Cognitive function and Brain structural changes associated with Ablation-therapy for Atrial fibrillation
Longitudinal study for Cognitive function and Brain structural changes associated with Ablation-therapy for Atrial fibrillation
Longitudinal study for Cognitive function and Brain structural changes associated with Ablation-therapy for Atrial fibrillation
Japan |
Atrial fibrillation
Cardiology | Neurology | Radiology |
Others
NO
The purpose of this study is to investigate a possible influence of Ablation therapy for patients with atrial fibrillation on cognitive function and brain structure and function using cognitive-psychological tests and brain magnetic resonance imaging (MRI)
Efficacy
(1) Cognitive function, (2)Gray matter volume, (3)Cerebral blood flow (CBF)
Comparison those parameters between before and after 6 months following Ablation therapy.
Observational
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Patients with paroxysmal or persistent atrial fibrillation in whom a clinical decision was made to perform ablation therapy.
Patients with a written informed consent.
(1)patients with past history of neuro-psychological disorders and significant organic diseases
(2)Patients with hemorrhagic symptoms
(3)Patients with coagulation defect associated with hepatic disease
(4)Patients with renal failure
(5)Patients with difficulty in obtaining written informed consent
(6)Patients in whom physician-in-charge decides unsuitable for this study
(7)Patients with difficulty in evaluating brain MRI:Patients undergoing Pacemaker-implantation, coronary artery stenting and other metal device implantation or patients with claustrophobia
(8)Patients with pregnancy
100
1st name | Yasuyuki |
Middle name | |
Last name | Taki |
Tohoku University, Institute of Development, Aging and cancer
Aging Research and Geriatric Medicine
980-8575
4-1, Seiryo, Aoba, Sendai, Miyagi, Japan
0227178559
ytaki@idac.tohoku.ac.jp
1st name | Yasuko |
Middle name | |
Last name | Tatewaki |
Tohoku University, Institute of Development, Aging and cancer
Aging Research and Geriatric Medicine
980-8575
4-1, Seiryo, Aoba, Sendai, Miyagi, Japan
022-717-8559
yasuko.tatewaki.a7@tohoku.ac.jp
Tohoku University, Institute of Development, Aging and cancer
Tohoku University, Institute of Development, Aging and cancer
Self funding
Tohoku University
1-1, Seiryo, Aoba, Sendai, Miyagi, Japan
022-717-8007
med-kenkyu@grp.tohoku.ac.jp
NO
2016 | Year | 07 | Month | 10 | Day |
https://www.mdpi.com/2077-0383/11/15/4346
Published
https://www.mdpi.com/2077-0383/11/15/4346
8
Cognitive-psychological function was improved, and rCBF was significantly increased in the left posterior cingulate cortex (PCC) (p=0.013), whereas decreased cortical thickness was found in the left posterior insular cortex (p =0.023).
2023 | Year | 07 | Month | 10 | Day |
This study enrolled eight right-handed patients with persistent AF who visited the division of Cardiology, Sendai City Hospital between 1 February 2016 and 31 July 2019. Eligible patients were those with persistent AF for whom a clinical decision was made to perform ablation therapy. The exclusion criteria for all patients were: neuro-psychological disorders, coexisting severe medical conditions or terminal diseases (e.g., stroke, Parkinson disease, thyroid/parathyroid disease, and cancer) that may influence the results of the imaging and cognitive studies, difficulty in obtaining written informed consent, difficulty in undergoing brain MRI (pacemaker-implantation, coronary artery stenting, other metal device implantation, or claustrophobia), difficulty in undergoing cognitive tests (amblyopia, deafness, orthopedic impairment), and failure to acquire rhythm control through ablation therapy.
All data and information regarding the clinical courses were collected and reviewed from medical records maintained by Sendai City Hospital. Before and 6 months after the latest ablation therapy by which rhythm control was acquired, cognitive-psychological tests, cardiac function with echocardiography, serum BNP concentrations, regional cerebral blood flow with ASL MRI, and regional cortical thickness with structural MRI were measured. The control group included seven subjects of similar age who had no arrhythmia and no organic or psychological disorders. They underwent cognitive psychological tests and MRI images for comparisons with the AF group.
N/A
rCBF, regional cortical thickness
Main results already published
2016 | Year | 06 | Month | 27 | Day |
2016 | Year | 06 | Month | 28 | Day |
2016 | Year | 08 | Month | 01 | Day |
2020 | Year | 03 | Month | 31 | Day |
This study is an observational study. The participants of this study include 100 patients with atrial fibrillation who plan to undergo ablation therapy with written-informed consent.
Participants will undergo cognitive tests and brain MRI at two-time points, before and after 6 months following ablation therapy.
2016 | Year | 07 | Month | 04 | Day |
2023 | Year | 07 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026521